Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scienjoy Holding (SJ) Cash & Equivalents (2019 - 2025)

Scienjoy Holding has reported Cash & Equivalents over the past 7 years, most recently at $43.4 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 23.38% year-over-year to $43.4 million; the TTM value through Dec 2025 reached $43.4 million, up 23.38%, while the annual FY2025 figure was $42.8 million, 21.81% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $43.4 million at Scienjoy Holding, up from $35499.7 in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $44.4 billion in Q2 2021 and troughed at $23215.8 in Q3 2022.
  • A 5-year average of $12.6 billion and a median of $35.6 million in 2024 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: surged 4058730058.73% in 2021 and later crashed 100.0% in 2025.
  • Year by year, Cash & Equivalents stood at $37.7 million in 2021, then crashed by 34.6% to $24.6 million in 2022, then increased by 15.78% to $28.5 million in 2023, then rose by 23.2% to $35.2 million in 2024, then rose by 23.38% to $43.4 million in 2025.
  • Business Quant data shows Cash & Equivalents for SJ at $43.4 million in Q4 2025, $35499.7 in Q3 2025, and $41.7 billion in Q2 2025.